https://www.b3cnewswire.com/202105102218/hearing-loss-company-acousia-therapeutics-presenting-at-upcoming-drug-development-and-b2b-conferences.html
Start of ACOU085 (Acousia Therapeutics) phase 1 study in patients with hearing loss is planned for the second half of 2021